[Federal Register Volume 63, Number 237 (Thursday, December 10, 1998)]
[Rules and Regulations]
[Pages 68182-68183]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 98-32741]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
21 CFR Part 522
Implantation or Injectable Dosage Form New Animal Drugs;
Gentamicin Sulfate Injection
AGENCY: Food and Drug Administration, HHS.
ACTION: Final rule.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is amending the animal
drug regulations to reflect approval of a supplemental new animal drug
application (NADA) filed by Merial Ltd. The supplemental NADA provides
for use of gentamicin sulfate injection in the neck of 1 to 3-day-old
turkey poults for prevention of early mortality due to susceptible
Arizona paracolon infections.
EFFECTIVE DATE: December 10, 1998.
FOR FURTHER INFORMATION CONTACT: Lonnie W. Luther, Center for
Veterinary Medicine (HFV-102), Food and Drug Administration, 7500
Standish Pl., Rockville, MD 20855, 301-827-0209.
SUPPLEMENTARY INFORMATION: Merial Ltd., 2100 Ronson Rd., Iselin, NJ
08830-3077, filed supplemental NADA 200-147 that provides for
subcutaneous use of Genta-Ject (gentamicin sulfate)
injectable solution in the neck of 1 to 3-day-old turkey poults as an
aid in the prevention of early mortality due to A. paracolon infections
susceptible to gentamicin. The supplemental NADA is approved as of
October 30, 1998, and the regulations are amended in 21 CFR
522.1044(b)(4) to reflect the approval. The basis of approval is
discussed in the freedom of information summary.
In accordance with the freedom of information provisions of 21 CFR
part 20 and 514.11(e)(2)(ii), a summary of safety and effectiveness
data and information submitted to support approval of this supplemental
application may be seen in the Dockets Management Branch (HFA-305),
Food and Drug Administration, 5630 Fishers Lane, rm. 1061, Rockville,
MD 20852, between 9 a.m. and 4 p.m., Monday through Friday.
The agency has determined under 21 CFR 25.33(a)(1) that this action
is of a type that does not individually or cumulatively have a
significant effect on the human environment. Therefore, neither an
environmental assessment nor an environmental impact statement is
required.
List of Subjects in 21 CFR Part 522
Animal drugs.
Therefore, under the Federal Food, Drug, and Cosmetic Act and under
authority delegated to the Commissioner of Food and Drugs and
redelegated to the Center for Veterinary Medicine, 21 CFR part 522 is
amended as follows:
PART 522--IMPLANTATION OR INJECTABLE DOSAGE FORM NEW ANIMAL DRUGS
1. The authority citation for 21 CFR part 522 continues to read as
follows:
Authority: 21 U.S.C. 360b.
2. Section 522.1044 is amended by revising paragraph (b)(4) to read
as follows:
Sec. 522.1044 Gentamicin sulfate injection.
* * * * *
(b) * * *
(4) See No. 050604 for use of 100 milligram-per-milliliter solution
in turkeys as in paragraph (d)(2) of this section and in chickens as in
paragraph (d)(3) of this section.
* * * * *
[[Page 68183]]
Dated: December 2, 1998.
Andrew J. Beaulieu,
Acting Director, Office of New Animal Drug Evaluation, Center for
Veterinary Medicine.
[FR Doc. 98-32741 Filed 12-9-98; 8:45 am]
BILLING CODE 4160-01-F
